Showing 3081-3090 of 3378 results for "".
- Sonrei Sea Clearly Gel Sunscreens Launchhttps://practicaldermatology.com/news/sonrei-sea-clearly-gel-sunscreens-launch/2460070/A new eco-friendly, gel-based sunscreen line from Sonrei, LLC is now available. “Crafted for every kind,” Sonrei is driven by a commitment of bringing to market a translucent broad-spectrum SPF with environmental principles at the core, the company says. Sonrei Sea Clearly T
- Crown Laboratories Unveils New Corporate Brandinghttps://practicaldermatology.com/news/crown-laboratories-unveils-new-corporate-branding/2460037/Crown Laboratories is launching its new corporate branding. Their new tagline 'Skin Science for Life' highlights the company’s focus on aesthetic medicine, generic and branded dermatological prescription drugs, OTC and prestig
- BullDog Skincare for Men Unveils New Eco-Friendly Packaging, Razorhttps://practicaldermatology.com/news/bulldog-skincare-for-men-unveils-new-eco-friendly-packaging-razor/2460021/With sweet new packaging and a bamboo razor, Bulldog Skincare For Men is once again raising the bar in men’s skincare. The always vegan-friendly and anti-animal testing brand is now dramatically reducing its carbon footprint by using Braz
- SkinBioTherapeutics Names New Executive Directorhttps://practicaldermatology.com/news/skinbiotherapeutics-names-new-executive-director/2460012/Stuart Ashman is the new executive director of SkinBioTherapeutics. Mr. Ashman will succeed Professor Cath O’Neill as CEO after a period of transition. Ms. O’Neill will continue to drive the science and the ongoing commercial
- Study Highlights Adverse Events Associated with Energy-Based Vaginal Rejuvenationhttps://practicaldermatology.com/news/study-highlights-adverse-events-associated-with-energy-based-vaginal-rejuvenation/2460010/Concerns from the federal Food and Drug Administration (FDA) sired the first assessment of adverse events related to device-based procedures marketed for ‘vaginal rejuvenation,’ and the new analysis of the Manufacturer and User Facility Device Experience (MAUDE) database identified a
- FDA Approves Ortho Dermatologics' Duobrii for Treatment of Plaque Psoriasishttps://practicaldermatology.com/news/fda-approves-ortho-dermatologics-duobrii-for-treatment-of-plaque-psoriasis/2460009/The FDA has approved Ortho Dermatologics' New Drug Application for Duobrii (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%, indicated for the topical treatment of plaque psoriasis in adults. Duobrii is the only topical lotion that contains a unique combination of halobetasol prop
- Alastin’s TransFORM Body Treatment May Enhance Cryolipolyis Outcomeshttps://practicaldermatology.com/news/alastins-transform-body-treatment-may-enhance-cryolipolyis-outcomes/2459996/Alastin’s TransFORM Body Treatment with TriHex Technology may accelerate outcomes seen with cryolipolysis, according to new research in the Journal of Drugs in Dermatology.
- Allergan 360° Aesthetics Report Shines Light on Evolving Beauty Perceptions Around the Worldhttps://practicaldermatology.com/news/allergan-3600-aesthetics-report-shines-light-on-evolving-beauty-perceptions-around-the-world/2459994/The digital boom and millennials are growing the aesthetics category, and wellness and self-care are the new key drivers, according to the Allergan 360° Aesthetics Report. To develop the report, Allergan tapped into more than 14,500
- FDA Approves Dupixent for Moderate to Severe AD in Adolescentshttps://practicaldermatology.com/news/us-fda-approves-dupixent-for-moderate-to-severe-atopic-dermatitis-in-adolescents/2459975/The FDA has approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA's eczema drug Dupixent to include patients aged 12 through 17 whose disease is not adequately controlled with topical prescription
- Physician Burnout Rates Fall Modestlyhttps://practicaldermatology.com/news/physician-burnout-rates-fall-modestly/2459892/The burnout rate among physicians in the United States has dropped, but there remains significant room for improvement, new data suggest. The burnout rate dropped modestly in 2017 from its peak in 2014. Current burnout rates are in line with 2011 levels. The triennial s